Page last updated: 2024-10-25

ciprofloxacin and Hypertension, Portal

ciprofloxacin has been researched along with Hypertension, Portal in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research Excerpts

ExcerptRelevanceReference
"In cirrhotic rats, ciprofloxacin suppressed endotoxemia and the hepatic endocannabinoid system thus ameliorating hyperdynamic circulation and decreased intrahepatic resistance by preventing hepatic fibrogenesis and endothelial dysfunction."3.77The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension. ( Huang, CM; Huang, YT; Lee, FY; Lee, SD; Lin, HC; Liu, TT; Tsai, TH; Yang, YY, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, HC1
Yang, YY1
Tsai, TH1
Huang, CM1
Huang, YT1
Lee, FY1
Liu, TT1
Lee, SD1

Other Studies

1 other study available for ciprofloxacin and Hypertension, Portal

ArticleYear
The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
    Journal of hepatology, 2011, Volume: 54, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cannabinoid Receptor Modulators; Ciprofloxacin; Disease Models, Anim

2011